Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willerson

Showing results (541-550 of 797) with videos related to

Pageof 80
Sort By:
The Journal of Clinical Investigation|February 1, 1984
Autoradiographic characterization of beta adrenergic receptors in coronary blood vessels and myocytes in normal and ischemic myocardium of the canine heartK H Muntz, E G Olson, G R Lariviere, et al.
Journal of Clinical Pharmacology|April 1, 1988
Epoprostenol (prostacyclin) in unstable anginaE Lichstein, R Mendizabal, P Theroux, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities studyAriel Brautbar, Christie M Ballantyne, Kim Lawson, et al.
Journal of the American College of Cardiology|July 1, 1985
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemiaG D Tilton, L M Buja, D W Bilheimer, et al.
Journal of the American College of Cardiology|August 16, 2005
Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trialPhilippe Garot, Thierry Lefèvre, Michael Savage, et al.
Circulation|April 1, 1994
Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteriesJ T Willerson, S K Yao, J McNatt, et al.
Circulation|April 1, 1979
Clinical implications of the technetium-99m stannous pyrophosphate myocardial scintigraphic "doughnut" pattern in patients with acute myocardial infarctsR E Rude, R W Parkey, F J Bonte, et al.
Zeitschrift Fur Kardiologie|February 24, 2001
[New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy]T W Jax, H C Eichstaedt, H S Shelat, et al.
The New England Journal of Medicine|January 20, 1972
The medical treatment of dissecting aortic aneurysmsJ McFarland, J T Willerson, R E Dinsmore, et al.
Circulation|May 1, 1979
Autonomic dysfunction in women with mitral valve prolapse syndromeF A Gaffney, E S Karlsson, W Campbell, et al.
Pageof 80

Showing results (541-550 of 797) with videos related to

Sort By:
Pageof 80
The Journal of Clinical Investigation|February 1, 1984
Autoradiographic characterization of beta adrenergic receptors in coronary blood vessels and myocytes in normal and ischemic myocardium of the canine heartK H Muntz, E G Olson, G R Lariviere, et al.
Journal of Clinical Pharmacology|April 1, 1988
Epoprostenol (prostacyclin) in unstable anginaE Lichstein, R Mendizabal, P Theroux, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities studyAriel Brautbar, Christie M Ballantyne, Kim Lawson, et al.
Journal of the American College of Cardiology|July 1, 1985
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemiaG D Tilton, L M Buja, D W Bilheimer, et al.
Journal of the American College of Cardiology|August 16, 2005
Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trialPhilippe Garot, Thierry Lefèvre, Michael Savage, et al.
Circulation|April 1, 1994
Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteriesJ T Willerson, S K Yao, J McNatt, et al.
Circulation|April 1, 1979
Clinical implications of the technetium-99m stannous pyrophosphate myocardial scintigraphic "doughnut" pattern in patients with acute myocardial infarctsR E Rude, R W Parkey, F J Bonte, et al.
Zeitschrift Fur Kardiologie|February 24, 2001
[New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy]T W Jax, H C Eichstaedt, H S Shelat, et al.
The New England Journal of Medicine|January 20, 1972
The medical treatment of dissecting aortic aneurysmsJ McFarland, J T Willerson, R E Dinsmore, et al.
Circulation|May 1, 1979
Autonomic dysfunction in women with mitral valve prolapse syndromeF A Gaffney, E S Karlsson, W Campbell, et al.
Pageof 80